Latest

XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals (Archive)

XPH faces looming patent cliffs and riskier orphan drug bets, pressuring future alpha.

OILK: Changing To A Bullish Stance (Archive)

Cautiously bullish on oil after OPEC+ cuts and China’s recovering demand and PMIs.

Johnson & Johnson: Negative Alpha Likely Ahead (Archive)

Technical analysis points to JNJ underperforming the S&P 500 in coming quarters.

Charles Schwab: Watch These Top 3 Metrics (Archive)

Waiting for three key metrics to confirm Schwab’s undervalued, but risky, opportunity.

Google: Look Up At The Cloud (Archive)

Cloud’s quietly becoming Google’s profit engine, with pricing and margins inflecting higher.

Energy Transfer: A Neutral Stand Amid A Tsunami Of Bullish Cheers (Archive)

The lone neutral voice amid Energy Transfer’s overwhelmingly bullish crowd.

Why I Think JEPI Will Outperform SCHD (Archive)

JEPI’s portfolio better reflects my macro views than SCHD’s, especially on energy.